Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Merck & Co., Inc.
  6. Financials
    MRK   US58933Y1055

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 198 695231 557206 957194 791--
Entreprise Value (EV)1 214 945247 453230 686205 835201 071198 881
P/E ratio 32,9x23,9x29,4x16,4x14,0x12,6x
Yield 2,60%2,48%3,03%3,40%3,64%3,87%
Capitalization / Revenue 4,70x4,94x4,31x4,21x3,91x3,79x
EV / Revenue 5,08x5,28x4,81x4,44x4,03x3,87x
EV / EBITDA 13,6x12,6x11,2x10,8x9,22x8,68x
Price to Book 7,42x9,00x8,18x7,04x5,96x5,03x
Nbr of stocks (in thousands) 2 600 3772 545 9842 530 0342 532 058--
Reference price (USD) 76,491,081,876,976,976,9
Announcement Date 02/01/201902/05/202002/04/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 42 29446 84047 99446 31849 87051 422
EBITDA1 15 78119 57220 57019 04821 81322 921
Operating profit (EBIT)1 13 92615 92016 94517 09019 61220 548
Operating Margin 32,9%34,0%35,3%36,9%39,3%40,0%
Pre-Tax Profit (EBT)1 8 70111 4648 79114 21517 34521 817
Net income1 6 2209 8437 06712 86714 56615 993
Net margin 14,7%21,0%14,7%27,8%29,2%31,1%
EPS2 2,323,812,784,705,516,08
Dividend per Share2 1,992,262,482,612,802,97
Announcement Date 02/01/201902/05/202002/04/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q3 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4
Net sales1 12 55112 51412 08011 20312 32712 288
EBITDA1 5 7444 6085 2204 5555 3834 719
Operating profit (EBIT)1 4 8923 7044 2904 0324 9464 433
Operating Margin 39,0%29,6%35,5%36,0%40,1%36,1%
Pre-Tax Profit (EBT)1 ---3 3672 8343 046
Net income1 2 941-2 0943 1792 8052 7122 905
Net margin 23,4%-16,7%26,3%25,0%22,0%23,6%
EPS2 1,16-0,831,250,821,211,19
Dividend per Share ------
Announcement Date 10/27/202002/04/202104/29/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 16 25015 89623 72911 0446 2794 090
Net Cash position1 ------
Leverage (Debt / EBITDA) 1,03x0,81x1,15x0,58x0,29x0,18x
Free Cash Flow1 8 3079 9675 56913 90916 52617 591
ROE (Net Profit / Equities) 38,1%50,9%58,9%44,0%44,7%41,0%
Shareholders' equity1 16 33519 34812 00129 26632 56739 013
ROA (Net Profit / Asset) 13,6%11,8%17,1%14,8%15,9%16,5%
Assets1 45 63183 51741 23187 14891 47996 902
Book Value Per Share2 10,310,110,010,912,915,3
Cash Flow per Share2 4,085,214,048,157,928,40
Capex1 2 6153 4734 6842 9503 4072 999
Capex / Sales 6,18%7,41%9,76%6,37%6,83%5,83%
Announcement Date 02/01/201902/05/202002/04/2021---
1 USD in Million
2 USD
Analysis
Exclusive-BlackRock backs 3 dissidents to shake up Exxon board -sources
Stock Pick
 MERCK AND COMPANY
Leader in oncology, modest valuation
Key data
Capitalization (USD) 194 791 249 942
Net sales (USD) 47 994 000 000
Number of employees 73 500
Sales / Employee (USD) 652 980
Free-Float 70,7%
Free-Float capitalization (USD) 137 757 888 925
Avg. Exchange 20 sessions (USD) 675 417 547
Average Daily Capital Traded 0,35%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA